These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 29530007)
1. Elevated α-defensin levels in plasma and bronchoalveolar lavage fluid from patients with myositis-associated interstitial lung disease. Sakamoto N; Ishimoto H; Kakugawa T; Satoh M; Hasegawa T; Tanaka S; Hara A; Nakashima S; Yura H; Miyamura T; Koyama H; Morita T; Nakamichi S; Obase Y; Ishimatsu Y; Mukae H BMC Pulm Med; 2018 Mar; 18(1):44. PubMed ID: 29530007 [TBL] [Abstract][Full Text] [Related]
2. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis. Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954 [TBL] [Abstract][Full Text] [Related]
3. Elevated plasma α-defensins in patients with acute exacerbation of fibrotic interstitial pneumonia. Sakamoto N; Ishimatsu Y; Kakugawa T; Yura H; Tomonaga M; Harada T; Nakashima S; Hara S; Hara A; Ishimoto H; Yatera K; Mukae H; Kohno S Respir Med; 2015 Feb; 109(2):265-71. PubMed ID: 25596137 [TBL] [Abstract][Full Text] [Related]
4. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases. Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213 [TBL] [Abstract][Full Text] [Related]
5. Decreased VEGF Level Is Associated with Elevated Ferritin Concentration in Bronchoalveolar Lavage Fluid of Children with Interstitial Lung Diseases. Papp Á; Bene Z; Gáspár I; Nagy B; Kádár L; Márialigeti T; Bánfi A; Baktai G; Balla G; Nagy B Respiration; 2015; 90(6):443-450. PubMed ID: 26473738 [TBL] [Abstract][Full Text] [Related]
6. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Ashitani J; Mukae H; Hiratsuka T; Nakazato M; Kumamoto K; Matsukura S Chest; 2002 Feb; 121(2):519-26. PubMed ID: 11834667 [TBL] [Abstract][Full Text] [Related]
7. [An evaluation of fibronectin and IgG in bronchoalveolar lavage fluid of patients with interstitial lung diseases]. Zhao HW; Lu CJ; Li ZH Zhonghua Jie He He Hu Xi Za Zhi; 1994 Apr; 17(2):93-5, 127. PubMed ID: 7994776 [TBL] [Abstract][Full Text] [Related]
8. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351 [TBL] [Abstract][Full Text] [Related]
9. CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis. Sfriso P; Cozzi F; Oliviero F; Caso F; Cardarelli S; Facco M; Fittà C; Del Rosso A; Matucci-Cerinic M; Punzi L; Agostini C Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S71-5. PubMed ID: 22691213 [TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of CCL18 in bronchoalveolar lavage fluid of connective tissue disease-associated interstitial lung disease]. He XW; Luo QZ; Shang Y; Gao ZC Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(38):2976-2981. PubMed ID: 31607028 [No Abstract] [Full Text] [Related]
11. Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients. Schmidt K; Martinez-Gamboa L; Meier S; Witt C; Meisel C; Hanitsch LG; Becker MO; Huscher D; Burmester GR; Riemekasten G Arthritis Res Ther; 2009; 11(4):R111. PubMed ID: 19615053 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia. Yura H; Sakamoto N; Satoh M; Ishimoto H; Hanaka T; Ito C; Hasegawa T; Tanaka S; Miyamura T; Nakashima S; Hara A; Kakugawa T; Oda K; Kido T; Obase Y; Ishimatsu Y; Yatera K; Kawakami A; Mukae H Respir Med; 2017 Nov; 132():189-194. PubMed ID: 29229096 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease. Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978 [TBL] [Abstract][Full Text] [Related]
15. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547 [TBL] [Abstract][Full Text] [Related]
16. High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Ashitani J; Mukae H; Arimura Y; Sano A; Tokojima M; Nakazato M Life Sci; 2004 Jul; 75(9):1123-34. PubMed ID: 15207659 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417 [TBL] [Abstract][Full Text] [Related]
18. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis. Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097 [TBL] [Abstract][Full Text] [Related]
19. sTREM-1 in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis, effect of smoking and inflammation. Suchankova M; Bucova M; E T; Demian J; Majer I; Novosadova H; Tedlova E; Durmanova V; Paulovicova E Bratisl Lek Listy; 2013; 114(12):702-7. PubMed ID: 24329508 [TBL] [Abstract][Full Text] [Related]
20. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]